๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Thrombocytopenia
Clinical trial register · China

Thrombocytopenia Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 3 Guangzhou 3 Wuhan 3 Hefei 2 Hangzhou 2
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing3 Guangzhou3 Wuhan3 Hefei2 Hangzhou2
All 17 locations
Target enrolment
to

Thrombocytopenia trials in China

12 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Efficacy and Safety of Romiplostim N01 for Injection in Promoting Platelet Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation
NCT07829952Thrombocytopenia, Allogeneic Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Henan University of Science and Technology
Phase 2
87
Luoyang
2026-11-01
Recruiting
Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)
NCT07441720Thrombocytopenia, Cancer Treatment-induced Thrombocytopenia
Zhejiang Cancer Hospital
Phase 2
25
Hangzhou
2026-02-28
Recruiting
Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT
NCT07442513Hematopoietic Stem Cell Transplantation, Thrombocytopenia
First Affiliated Hospital of Zhejiang University
Phase 3
404
Hangzhou
2025-12-16
Recruiting
Herombopag Treated T-DM1 Induced Platelet Reduction
NCT07257809Thrombocytopenia
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
56
Guangzhou
2025-10-13
Recruiting
Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT)
NCT07110090Thrombocytopenia, Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1
16
Beijing
2025-08-28
Not yet open
The Study of Different Cycles of High-dose Dexamethasone in the Treatment of ITP
NCT06913374Thrombocytopenia
Shandong University
Phase 2/3
118
Jinan
2025-05-01
Recruiting
UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
NCT06245746Acute Myeloid Leukemia, Neutropenia, Anemia, Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1
9
Wuhan
2025-02-26
Recruiting
Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT
NCT06202625Thrombocytopenia, Stem Cell Transplant Complications
Peking University People's Hospital
Phase 2/3
142
Beijing, Guangzhou, Shenzhen, Harbin, Zhengzhou, Wuhan, Changsha, Nanchang
2024-05-13
Recruiting
Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
NCT05998759Connective Tissue Diseases, Thrombocytopenia
Beijing Hospital
Phase 2
296
Hefei, Beijing, Guangzhou, Zhengzhou, Wuhan, Changsha, Hohhot, Shenyang
2023-12-02
Recruiting
Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia
NCT05199909Antiphospholipid Syndrome, Thrombocytopenia, Treatment
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
10
Tianjin
2022-01-25
Rows per page Showing 1–12 of 12
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/thrombocytopenia

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 12 of those studies listing the condition Thrombocytopenia.

How many Thrombocytopenia trials are recruiting in China?

9 of the 12 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Thrombocytopenia), 12 studies
PhaseStudiesRecruitingShare
Phase 26550%
Phase 12216.7%
Phase 2/32116.7%
Not applicable108.3%
Phase 3118.3%

Most active sponsors

Lead sponsors with the most studies (Thrombocytopenia)
Lead sponsorStudiesRecruiting
Anhui Provincial Hospital11
Beijing Hospital11
Cancer Institute and Hospital, Chinese Academy of Medical Sciences11
First Affiliated Hospital of Zhejiang University11
Institute of Hematology & Blood Diseases Hospital, China11
Jun wang10
Peking University People's Hospital11
Shandong University10
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University11
The First Affiliated Hospital of Henan University of Science and Technology10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.